Conversely, our findings regarding METTL14 expression differed from previous reports as four studies indicated reduced METTL14 levels in BRCA and BLCA, contradicting our results [96,97,98,99]. The gene discussed is METTL14; the disease is bladder transitional cell carcinoma.